Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
| Brand name | NEOMYCIN SULFATE |
| Generic name | NEOMYCIN SULFATE |
| Active ingredient(s) | NEOMYCIN SULFATE |
| Distributed by / for | TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454 |
| NDC | 0093-1177-01 |
| Full product label | Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01 |
| Recalling firm | Teva Pharmaceuticals USA Inc |
| Distribution | Nationwide within the United States |
| Recall initiated | 2022-08-23 |
| Report date | 2022-09-07 |
| Recall completed | 2023-09-07 |
| Recall number | D-1473-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗